The latest news on transcatheter mitral and tricuspid therapies

Access Now: Get ready for your journey with the EVOQUE System in TMTT Today Magazine #12

TMTT Today #12 – July 2024

Explore evidence from TRISCEND study and TRISCEND II pivotal trial demonstrating that the EVOQUE system is a promising option for patients with symptomatic severe TR.
Find out about the challenges of treating TR and recent advances in transcatheter tricuspid valve intervention.
Discover insights into the development of the world’s first transfemoral tricuspid valve replacement system.*
Read tips and tricks from a series of 3 cases with the EVOQUE and PASCAL Precision systems
^{*First-of-its kind device commercially available (in the EU).}

Get your copy

Discover our previous issues

TMTT Today #11 – April 2024

MR Reduction, TEER Advances & Atraumatic Implants

Explore the significant MR reduction with the CLASP IID RCT and 1-year outcomes, and discover our latest TEER innovation with reusable accessories for PASCAL Precision system procedures. Learn about the atraumatic clasp and closure of PASCAL implants, along with inside tips for treating MR patients.

Download

TMTT Today #10 – September 2023

Evidence from post-market and real-world studies

Explore the Mitral TEER: MiCLASP post-market study, 1-year results from the PASTE registry for Tricuspid TEER, and tips for using the PASCAL Precision system in MR and TR. All in our latest issue!

Download

TMTT Today #9 – February 2023

PASCAL Precision System: Designed for precise placement with accurate, intuitive control*

Read more to discover perspectives from early users of the PASCAL Precision system in patients with mitral and tricuspid regurgitation.

^{* Performance data on file and marketing evaluation}

Download

TMTT Today #8 – September 2022

PASCAL Platform showing unparalleled TR outcomes

Read more to discover the latest evidence on tricuspid therapies and experts' suggestions for the selection of PASCAL implants to treat MR.

^{Caution: Cardioband Tricuspid System only approved in EU market until 24 May 2024.}

Download

TMTT Today #7 – February 2022

PASCAL Platform: Bringing you predictable and sustained MR reduction

Read more about the predictability of the PASCAL repair system in minimising residual MR, the latest data from clinical and real-world studies, and much more!

Download Watch

TMTT Today #6 – October 2021

Discover the latest evidence on TR*

Learn about the most current evidence and real-world experience on Edwards Lifesciences' portfolio of therapies for TR.

^{* Caution: Cardioband Tricuspid System only approved in EU market until 24 May 2024.}

Download Watch

TMTT Today #5 – May 2021

Stability, control and procedural confidence with the new PASCAL Stabilizer Rail System*

Discover the new PASCAL Stabilizer Rail System, the latest advancements in treating TR, and PASCAL real-world data on both MR and TR.

^{* Caution: Cardioband Tricuspid System only approved in EU market until 24 May 2024}

Download

TMTT Today #4 – April 2021

Getting up to speed with the PASCAL Platform

Make the most of the PASCAL platform to deliver optimal outcomes for your MR and TR patients.

Download Watch

TMTT Today #3 – December 2020

The PASCAL Platform. A complete solution for transcatheter mitral and tricuspid valve repair

Reporting the PASCAL platform impressive outcomes in mitral and tricuspid valve repair.

Download

Stay up to date with future developments by subscribing to the Edwards Lifesciences mailing list today.

MR, mitral regurgitation; TMTT, transcatheter mitral and tricuspid therapies; TR, tricuspid regurgitation; TEER, transcatheter edge-to-edge repair; RCT, Randomized controlled clinical trials.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).